Although the minimal-model-based insulin sensitivity index (S1) can be estimated from the results of a simple 180-min intravenous glucose tolerance test (IVGTT), its relationship to widely accepted but technically more difficult clamp-based techniques has not been resolved in humans. Therefore we measured S1 by standard IVGTT, modified IVGTT, and clamp methods in 10 nondiabetic men with %IBW of 109 ± 12 (mean ± SD). In the euglycemic clamp studies, insulin was infused to bring insulin levels (IRI) from basal, 8 ± 4 μU/ml, to plateaus of 21 ± 5 and 35 ± 6 μU/ml. S1[clamp], measured as the increase in glucose (G) clearance per increase in IRI [δINF/(δIRI × G)], averaged 0.29 ± 0.09 ml/kg·min per μU/ml. In the IVGTT studies, 300 mg/kg G was given as an i.v. bolus, and G and IRI were measured for 180 min; in the modified (mod) IVGTT, tolbutamide (300–500 mg) was given i.v. 20 min after the G to observe the effect of an IRI peak on G removal after G level was free of initial “mixing” effects. The S1 estimated by computer did not differ significantly between standard [(6.9 ± 3.4) × 1O−4 min−1 per μU/ml] and modified [(6.7 ± 3.5) × 10−4 min−1 per μU/ml] tests, indicating no bias due to the differing insulin patterns and levels. There was a strong positive correlation between S1 (mod IVGTT) and S1(clamp): r = 0.84; N = 10; P < 0.002. The correlation between S1(standard IVGTT) and S1(clamp) was 0.54, suggesting the modified test is less “noisy” Nonetheless, in eight euglycemic women with a wider range of adiposity, S1(standard IVGTT) has been significantly correlated with %IBW (r = −0.72) and basal IRI (r = −0.84). The correlation between S1 measures by clamp and IVGTT methods provides one step toward validation of the minimal model for studies of insulin action in man.

This content is only available via PDF.